Previous close | 0.6332 |
Open | 0.6600 |
Bid | 0.3778 x 800 |
Ask | 0.9490 x 900 |
Day's range | 0.6332 - 0.6600 |
52-week range | 0.3800 - 1.6000 |
Volume | |
Avg. volume | 10,135 |
Market cap | 27.492M |
Beta (5Y monthly) | -0.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 23 Dec 2015 |
1y target est | N/A |
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure perio
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced the listing of a minority stake of 39,420,200 H shares in Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), its subsidiary, at an initial public offer price of HK$14.28 per H share on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...